These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9658325)

  • 21. Embolization of spontaneous splenorenal shunt for after-TIPS hepatic encephalopathy in a patient with cirrhosis and variceal bleeding.
    Wu W; He C; Han G
    Hepatology; 2015 May; 61(5):1761-2. PubMed ID: 25212730
    [No Abstract]   [Full Text] [Related]  

  • 22. Balloon occlusion retrograde transvenous obliteration for inferior mesenteric vein-systemic shunt.
    Minamiguchi H; Kawai N; Sato M; Ikoma A; Sawa M; Sonomura T; Sahara S; Nakata K; Tanaka T; Takasaka I; Nakai M
    J Vasc Interv Radiol; 2011 Jul; 22(7):1039-44. PubMed ID: 21708323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portosplenic blood flow separation in a patient with portosystemic encephalopathy and a spontaneous splenorenal shunt.
    Zamora CA; Sugimoto K; Tsurusaki M; Yamaguchi M; Izaki K; Taniguchi T; Iwama Y; Mimura F; Sugimura K
    J Vasc Interv Radiol; 2004 Aug; 15(8):875-9. PubMed ID: 15297594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transjugular retrograde obliteration for chronic portosystemic encephalopathy.
    Chikamori F; Kuniyoshi N; Shibuya S; Takase Y
    Abdom Imaging; 2000; 25(6):567-71. PubMed ID: 11029085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic encephalopathy from dual splenorenal shunts treated with balloon-occluded retrograde transvenous obliteration by using a double-balloon technique.
    Matake K; Tajima T; Yoshimitsu K; Irie H; Aibe H; Nishie A; Asayama Y; Honda H
    J Vasc Interv Radiol; 2007 Nov; 18(11):1436-40. PubMed ID: 18003996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Embolization of portal-systemic shunts in cirrhotic patients with chronic recurrent hepatic encephalopathy.
    Sakurabayashi S; Sezai S; Yamamoto Y; Hirano M; Oka H
    Cardiovasc Intervent Radiol; 1997; 20(2):120-4. PubMed ID: 9030502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Using Ethanolamine Oleate (EO), BRTO Using Sodium Tetradecyl Sulfate (STS) Foam and Vascular Plug-Assisted Retrograde Transvenous Obliteration (PARTO).
    Kim YH; Kim YH; Kim CS; Kang UR; Kim SH; Kim JH
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):840-6. PubMed ID: 26757912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intrahepatic portosystemic venous shunt via right renal vein successfully treated with balloon-occluded retrograde transvenous obliteration].
    Hashiguchi K; Yamasaki K; Ichikawa T; Takeshima F; Nakao K
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1726-34. PubMed ID: 21971147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrograde transvenous obliteration of gastric varices associated with large collateral veins or a large gastrorenal shunt.
    Sugimori K; Morimoto M; Shirato K; Kokawa A; Tomita N; Numata K; Saito T; Tanaka K
    J Vasc Interv Radiol; 2005 Jan; 16(1):113-8. PubMed ID: 15640418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid Surgery for Portosystemic Encephalopathy in a Patient with Liver Cirrhosis: a case report.
    Imaoka Y; Ohira M; Kuroda S; Tahara H; Ide K; Ishiyama K; Kobayashi T; Ishikawa M; Awai K; Ohdan H
    Hiroshima J Med Sci; 2017 Mar; 66(1):11-15. PubMed ID: 29986123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-TIPS hepatic encephalopathy treated by occlusion balloon-assisted retrograde embolization of a coexisting spontaneous splenorenal shunt.
    Shioyama Y; Matsueda K; Horihata K; Kimura M; Nishida N; Kishi K; Terada M; Sato M; Yamada R
    Cardiovasc Intervent Radiol; 1996; 19(1):53-5. PubMed ID: 8653749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective embolization of the splenic vein in patients with hepatic encephalopathy and splenorenal shunt.
    Mezawa S; Homma H; Akiyama T; Katsuki S; Murakami K; Hirata K; Kogawa K; Takahashi S; Sato T; Doi T; Niitsu Y
    J Vasc Interv Radiol; 2004 Dec; 15(12):1475-81. PubMed ID: 15590808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.
    Ibukuro K; Sugihara T; Tanaka R; Fukuda H; Abe S; Tobe K; Tateishi R; Tagawa K
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):121-5. PubMed ID: 17296712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
    Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a new coaxial balloon catheter system for balloon-occluded retrograde transvenous obliteration (B-RTO).
    Tanoue S; Kiyosue H; Matsumoto S; Hori Y; Okahara M; Kashiwagi J; Mori H
    Cardiovasc Intervent Radiol; 2006; 29(6):991-6. PubMed ID: 16736100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration.
    Akahane T; Iwasaki T; Kobayashi N; Tanabe N; Takahashi N; Gama H; Ishii M; Toyota T
    Am J Gastroenterol; 1997 Jun; 92(6):1026-30. PubMed ID: 9177524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balloon-occluded retrograde transvenous obliteration of gastric varix via the pericardiacophrenic vein.
    Yoshimatsu R; Yamagami T; Tanaka O; Miura H; Okuda K; Nishimura T
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S206-9. PubMed ID: 20390275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Balloon-occluded retrograde transvenous obliteration for portal-systemic encephalopathy due to superior mesenteric-caval shunt via the right gonadal vein.
    Katamura Y; Aikata H; Azakami T; Kawaoka T; Uka K; Yamashina K; Takaki S; Kodama H; Cheol JS; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Toyota N; Ito K; Chayama K
    Intern Med; 2007; 46(17):1479-80. PubMed ID: 17827854
    [No Abstract]   [Full Text] [Related]  

  • 40. Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient.
    Uehara H; Akahoshi T; Tomikawa M; Kinjo N; Hashimoto N; Nagao Y; Kamori M; Maehara Y
    J Gastroenterol Hepatol; 2012 Jan; 27(1):137-41. PubMed ID: 21722180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.